{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T07:47:30Z","timestamp":1769586450458,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","brachyjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.brachy.2024.03.003","type":"journal-article","created":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T11:07:26Z","timestamp":1713524846000},"page":"397-406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Dosimetric and toxicity comparison between Syed-Neblett and Fletcher-Suit-Delclos Tandem and Ovoid applicators in high dose rate cervix cancer brachytherapy"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5928-3020","authenticated-orcid":false,"given":"Andres","family":"Portocarrero-Bonifaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salman","family":"Syed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxwell","family":"Kassel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6737-3966","authenticated-orcid":false,"given":"Grant W.","family":"McKenzie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0433-2737","authenticated-orcid":false,"given":"Vishwa M.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryce M.","family":"Forry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6284-3404","authenticated-orcid":false,"given":"Jeremy T.","family":"Gaskins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith T.","family":"Sowards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6897-9712","authenticated-orcid":false,"given":"Thulasi Babitha","family":"Avula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrianna","family":"Masters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6028-3685","authenticated-orcid":false,"given":"Scott R.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2024.03.003_bib0001","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.brachy.2024.03.003_bib0002","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ygyno.2012.05.035","article-title":"Changing demographics of cervical cancer in the United States (1973\u20132008)","volume":"126","author":"Ward","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2024.03.003_bib0003","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ijgo.12611","article-title":"Cancer of the cervix uteri","volume":"143","author":"Bhatla","year":"2018","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.brachy.2024.03.003_bib0004","doi-asserted-by":"crossref","first-page":"718","DOI":"10.15585\/mmwr.mm6833a2","article-title":"National, regional, state, and selected local area vaccination coverage among adolescents aged 13\u201317 years\u2014United States, 2018","volume":"68","author":"Walker","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.brachy.2024.03.003_bib0005","doi-asserted-by":"crossref","first-page":"djx030","DOI":"10.1093\/jnci\/djx030","article-title":"Annual report to the nation on the status of cancer, 1975\u20132014, featuring survival","volume":"109","author":"Jemal","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.brachy.2024.03.003_bib0006","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.brachy.2024.03.003_bib0007","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1002\/cncr.30667","article-title":"Cervical cancer: a global health crisis","volume":"123","author":"Small","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2024.03.003_bib0008","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1470-2045(20)30753-1","article-title":"MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study","volume":"22","author":"Potter","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.brachy.2024.03.003_bib0009","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijrobp.2013.05.033","article-title":"Trends in the utilization of brachytherapy in cervical cancer in the United States","volume":"87","author":"Han","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2024.03.003_bib0010","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.ijrobp.2015.03.010","article-title":"Image-based brachytherapy for the treatment of cervical cancer","volume":"92","author":"Harkenrider","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2024.03.003_bib0011","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.brachy.2018.01.003","article-title":"Improving dose delivery by adding interstitial catheters to fixed geometry applicators in high-dose-rate brachytherapy for cervical cancer","volume":"17","author":"Otter","year":"2018","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2024.03.003_bib0012","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.ijrobp.2019.12.019","article-title":"Ring versus ovoids and intracavitary versus intracavitary-interstitial applicators in cervical cancer brachytherapy: results from the EMBRACE I study","volume":"106","author":"Serban","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2024.03.003_bib0013","doi-asserted-by":"crossref","first-page":"218","DOI":"10.5114\/jcb.2015.51853","article-title":"Short-term clinical outcome and dosimetric comparison of tandem and ring versus tandem and ovoids intracavitary applicators","volume":"7","author":"Ma","year":"2015","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2024.03.003_bib0014","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.brachy.2012.11.002","article-title":"Clinical outcomes of high-dose-rate interstitial gynecologic brachytherapy using real-time CT guidance","volume":"12","author":"Lee","year":"2013","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2024.03.003_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jicru_ndw042","article-title":"Prescribing, Recording, and Reporting Brachytherapy for Cancer of the Cervix","volume":"13","year":"2013","journal-title":"J ICRU"},{"key":"10.1016\/j.brachy.2024.03.003_bib0016","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.radonc.2021.01.019","article-title":"Risk factors and dose-effects for bladder fistula, bleeding and cystitis after radiotherapy with imaged-guided adaptive brachytherapy for cervical cancer: an EMBRACE analysis","volume":"158","author":"Spampinato","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2024.03.003_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109501","article-title":"Association of persistent morbidity after radiotherapy with quality of life in locally advanced cervical cancer survivors","volume":"181","author":"Spampinato","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2024.03.003_bib0018","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1200\/JCO.2008.20.2424","article-title":"Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial","volume":"27","author":"Nout","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2024.03.003_bib0019","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.ijrobp.2015.12.363","article-title":"Health-related quality of life in locally advanced cervical cancer patients after definitive chemoradiation therapy including image guided adaptive brachytherapy: an analysis from the EMBRACE study","volume":"94","author":"Kirchheiner","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2024.03.003_bib0020","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.radonc.2005.11.014","article-title":"Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy\u20143D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology","volume":"78","author":"P\u00f6tter","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2024.03.003_bib0021","unstructured":"National Cancer Institute. (2018). Common terminology criteria for adverse events (CTCAE). Available at: https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm. Accessed November 28, 2023."},{"key":"10.1016\/j.brachy.2024.03.003_bib0022","unstructured":"R Core Team (2022). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. Available at: https:\/\/www.R-project.org\/. Accessed November 28, 2023."},{"key":"10.1016\/j.brachy.2024.03.003_bib0023","doi-asserted-by":"crossref","first-page":"e983","DOI":"10.1002\/mp.15713","article-title":"AAPM task group report 303 endorsed by the ABS: MRI implementation in HDR brachytherapy\u2014considerations from simulation to treatment","volume":"49","author":"Prisciandaro","year":"2022","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2024.03.003_bib0024","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.prro.2020.04.002","article-title":"Radiation therapy for cervical cancer: executive summary of an ASTRO clinical practice guideline","volume":"10","author":"Chino","year":"2020","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.brachy.2024.03.003_bib0025","doi-asserted-by":"crossref","first-page":"202","DOI":"10.5114\/jcb.2018.76782","article-title":"Dosimetric evaluation of point A and volume-based high-dose-rate plans: a single institution study on adaptive brachytherapy planning for cervical cancer","volume":"10","author":"Paul","year":"2018","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2024.03.003_bib0026","doi-asserted-by":"crossref","first-page":"551","DOI":"10.5114\/jcb.2022.123975","article-title":"Comparison of vaginal gauze packing technique with or without balloon in high-dose-rate brachytherapy of uterine cervical cancer: a crossover randomized controlled trial","volume":"14","author":"Dhanapalan","year":"2022","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2024.03.003_bib0027","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1200\/JCO.22.01096","article-title":"Risk factors for local failure following chemoradiation and magnetic resonance image\u2013guided brachytherapy in locally advanced cervical cancer: results from the EMBRACE-I study","volume":"41","author":"Schmid","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2024.03.003_bib0028","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ygyno.2018.11.020","article-title":"Inversely and adaptively planned interstitial brachytherapy: a single implant approach","volume":"152","author":"Hanania","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2024.03.003_bib0029","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.brachy.2016.10.005","article-title":"Toxicities and dose\u2013volume histogram parameters of MRI-based brachytherapy for cervical cancer","volume":"16","author":"Kim","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2024.03.003_bib0030","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.brachy.2011.06.005","article-title":"Inverse-planned gynecologic high-dose-rate interstitial brachytherapy: clinical outcomes and dose\u2013volume histogram analysis","volume":"11","author":"Thibault","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2024.03.003_bib0031","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.meddos.2008.06.003","article-title":"Dosimetric comparison of tandem and ovoids vs tandem and ring for intracavitary gynecologic applications","volume":"33","author":"Levin","year":"2008","journal-title":"Med Dosim"},{"key":"10.1016\/j.brachy.2024.03.003_bib0032","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.rpor.2017.12.006","article-title":"Dosimetric evaluation of image-based brachytherapy using tandem ovoid and tandem ring applicators","volume":"23","author":"Rangarajan","year":"2018","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.brachy.2024.03.003_bib0033","first-page":"698","article-title":"Long-term clinical outcome and dosimetric comparison of tandem and ring versus tandem and ovoids intracavitary application in cervical cancer","volume":"26","author":"Atasever-Akkas","year":"2021","journal-title":"J BUON"},{"key":"10.1016\/j.brachy.2024.03.003_bib0034","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.brachy.2016.09.009","article-title":"Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients","volume":"16","author":"Koh","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2024.03.003_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13014-018-1074-2","article-title":"High dose-rate tandem and ovoid brachytherapy in cervical cancer: dosimetric predictors of adverse events","volume":"13","author":"Romano","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.brachy.2024.03.003_bib0036","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.brachy.2016.03.008","article-title":"American Brachytherapy Task Group Report: a pooled analysis of clinical outcomes for high-dose-rate brachytherapy for cervical cancer","volume":"16","author":"Mayadev","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2024.03.003_bib0037","first-page":"48","article-title":"The EMBRACE II study: the outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies","volume":"9","author":"P\u00f6tter","year":"2018","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.brachy.2024.03.003_bib0038","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.radonc.2011.07.012","article-title":"Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer","volume":"100","author":"P\u00f6tter","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.brachy.2024.03.003_bib0039","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.3109\/0284186X.2013.818253","article-title":"MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective","volume":"52","author":"Lindegaard","year":"2013","journal-title":"Acta Oncol"},{"key":"10.1016\/j.brachy.2024.03.003_bib0040","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1118\/1.2776669","article-title":"Investigation of the support vector machine algorithm to predict lung radiation-induced pneumonitis","volume":"34","author":"Chen","year":"2007","journal-title":"Med Phys"},{"key":"10.1016\/j.brachy.2024.03.003_bib0041","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.brachy.2019.04.004","article-title":"A machine-learning\u2013based prediction model of fistula formation after interstitial brachytherapy for locally advanced gynecological malignancies","volume":"18","author":"Tian","year":"2019","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2024.03.003_bib0042","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3389\/fonc.2020.00790","article-title":"Machine learning-based models for prediction of toxicity outcomes in radiotherapy","volume":"10","author":"Isaksson","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.brachy.2024.03.003_bib0043","article-title":"Machine learning for the prediction of toxicities from head and neck cancer treatment: a systematic review with meta-analysis","volume":"140","author":"Damaceno-Ara\u00fajo","year":"2023","journal-title":"Oral Oncol"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153847212400045X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153847212400045X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T06:59:10Z","timestamp":1732172350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153847212400045X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S153847212400045X"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2024.03.003","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dosimetric and toxicity comparison between Syed-Neblett and Fletcher-Suit-Delclos Tandem and Ovoid applicators in high dose rate cervix cancer brachytherapy","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2024.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}